Evidence map›Paper›PMID 20889095›Full record

ArticleJournal of the American Medical Directors Association2010

Is withholding osteoporosis medication after fracture sometimes rational? A comparison of the risk for second fracture versus death.

Jeffrey R Curtis, Tarun Arora, Robert S Matthews, Allison Taylor, David J Becker, Cathleen Colon-Emeric, Meredith L Kilgore, Michael A Morrisey, Kenneth G Saag, Monika M Safford and 2 more

Open access · greenAbstract readComparative Study
In one paragraph

Article in Journal of the American Medical Directors Association, 2010. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 26 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
26citing papers in PubMed, 1 pooled it
4.0field-weighted citation impact, top 7% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

26 citing papers in PubMed, 1 synthesis or guideline pooled it, 59 citations in OpenAlex.

  1. Pooled it
  2. Fracture prevention in patients with cognitive impairment presenting with a hip fracture: secondary analysis of data from the HORIZON Recurrent Fracture Trial.Osteoporosis international : a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA · 2014
    Trial
  3. Multimodal intervention to improve osteoporosis care in home health settings: results from a cluster randomized trial.Osteoporosis international : a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA · 2013
    Trial
  4. Article
  5. Article
  6. Characteristics Associated With 5-Year Fracture Risk Versus 5-Year Mortality Risk Among Late-Life Men.The journals of gerontology. Series A, Biological sciences and medical sciences · 2023
    Article
  7. Distal radius fractures and risk of incident neurocognitive disorders in older adults: a retrospective cohort study.Osteoporosis international : a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA · 2022
    Article
  8. Article
  9. Article
  10. Estimated Direct Medical Cost of Osteoporosis in Saudi Arabia: A Single-Center Retrospective Cost Analysis.International journal of environmental research and public health · 2021
    Article
  11. Article
  12. Article
  13. Review
  14. Incidence of subsequent fractures in the UK between 1990 and 2012 among individuals 50 years or older.Osteoporosis international : a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA · 2018
    Observational
  15. Review
  16. Article
  17. Anti-Osteoporosis Medication Prescriptions and Incidence of Subsequent Fracture Among Primary Hip Fracture Patients in England and Wales: An Interrupted Time-Series Analysis.Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research · 2016
    Article
  18. Wrist Fracture and Risk of Subsequent Fracture: Findings from the Women's Health Initiative Study.Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research · 2015
    Article
  19. The risk of major and any (non-hip) fragility fracture after hip fracture in the United Kingdom: 2000-2010.Osteoporosis international : a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA · 2014
    Article
  20. Death, debility, and destitution following hip fracture.The journals of gerontology. Series A, Biological sciences and medical sciences · 2014
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors at 2 institutions in 1 country.

Jeffrey R CurtisDivision of Clinical Immunology and Rheumatology, University of Alabama at Birmingham, Birmingham, AL 35294, USA. jcurtis@uab.edu
Tarun Arora
Robert S Matthews
Allison Taylor
David J Becker
Cathleen Colon-Emeric
Meredith L Kilgore
Michael A Morrisey
Kenneth G Saag
Monika M Safford
Amy Warriner
Elizabeth Delzell
University of Alabama at Birmingham · USDuke University · US

Funding

Deep South Musculoskeletal (DSM) CERTsU18HS016956 · AHRQ · UNIVERSITY OF ALABAMA AT BIRMINGHAM · PI SAAG, KENNETH G · 2007 to 2010
$3.7M
Mid-Career Investigator Award (for Kenneth G. Saag, MD, MSc)K24AR052361 · NIAMS · UNIVERSITY OF ALABAMA AT BIRMINGHAM · PI SAAG, KENNETH G · 2005 to 2014
$1.7M
Ethnic Differences in the Risk of Fracture and Vascular DiseaseK23AR053351 · NIAMS · UNIVERSITY OF ALABAMA AT BIRMINGHAM · PI CURTIS, JEFFREY R. · 2007 to 2011
$755k
AHRQ HHS U18 HS016956NIAMS NIH HHS AR052361NIAMS NIH HHS AR053351NIAMS NIH HHS K23 AR053351NIAMS NIH HHS K24 AR052361
6 · The paper itself

Abstract

introductionUndertreatment of osteoporosis is common, even for high-risk patients. Among the reasons for undertreatment may be a clinician's perception of a lack of treatment benefit, particularly in light of patients' expected future mortality. Among US Medicare beneficiaries, we evaluated the risk for second fracture versus death in the 5 years following a hip, clinical vertebral, and wrist/forearm fracture.

methodsUsing data from 1999 to 2006 for a random 5% sample of US Medicare beneficiaries, we identified individuals who experienced an incident hip, clinical vertebral, or wrist/forearm fracture in 2000 or 2001. We evaluated the risk for a second incident fracture versus death in the following 5 years. Results were stratified by age, gender, race/ethnicity, and medical comorbidities. In light of the competing mortality risk, and assuming 30% efficacy of an osteoporosis medication to prevent a second fracture, we calculated the number of individuals needed to treat (NNT) for 5 years after first fracture to prevent 1 additional subsequent fracture.

resultsWe identified 18,853, 12,751, and 7635 persons with an incident hip, clinical vertebral, and wrist/forearm fracture, respectively. Although the 5-year risk of death usually exceeded the risk for second fracture across age, gender, racial groups, and primary fracture type (median ratio of death to second fracture=1.4, interquartile range 0.9, 2.0), the 5-year risk for second fracture was high, varying from a low of 13% to a high of 43%. Across demographic groups, the NNT to prevent a second fracture was low, ranging from 8 to 46.

conclusionAmong older persons with hip, clinical vertebral, or wrist/forearm fracture, although the risk for death was usually greater than the risk for a second fracture, both were high. The relatively low NNT to prevent 1 additional subsequent fracture fell within a range generally considered acceptable for secondary prevention strategies.

Indexed as

DeathWithholding TreatmentAgedAged, 80 and overCenters for Medicare and Medicaid Services, U.S.FemaleFractures, BoneHumansInsurance Claim ReviewMaleOsteoporosisRisk AssessmentSecondary PreventionStatistics as TopicUnited States

Identifiers

PMID20889095
PMCPMC2950120
OpenAlexW2003929342

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.